Class II

Drug Recall: Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in Ind

Mylan Institutional, Inc. · March 7, 2025

Reason for Recall

Super-Potent Drug: Out of specification potency results were obtained.

Product Description

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.

Distribution

Nationwide in the USA

States Affected

NATIONWIDE

Quantity Affected

347 Cartons

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0290-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.